<VariationArchive RecordType="classified" VariationID="992640" VariationName="NM_001082486.2(ACD):c.361del (p.Asp121fs)" VariationType="Deletion" Accession="VCV000992640" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-06-19" MostRecentSubmission="2021-06-19">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="980564" VariationID="992640">
      <GeneList>
        <Gene Symbol="ACD" FullName="ACD shelterin complex subunit and telomerase recruitment factor" GeneID="65057" HGNC_ID="HGNC:25070" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67657512" stop="67660260" display_start="67657512" display_stop="67660260" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67691414" stop="67694717" display_start="67691414" display_stop="67694717" Strand="-" />
          </Location>
          <OMIM>609377</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACD">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ACD">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001082486.2(ACD):c.361del (p.Asp121fs)</Name>
      <CanonicalSPDI>NC_000016.10:67659588:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="67659589" stop="67659589" display_start="67659589" display_stop="67659589" variantLength="1" positionVCF="67659588" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="67693492" stop="67693492" display_start="67693492" display_stop="67693492" variantLength="1" positionVCF="67693491" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>D118fs</ProteinChange>
      <ProteinChange>D121fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.67659590del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.67659590del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.67693493del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.67693493del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042874.1" sequenceAccession="NG_042874" sequenceVersion="1" change="g.6227del">
            <Expression>NG_042874.1:g.6227del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001082486.2" sequenceAccession="NM_001082486" sequenceVersion="2" change="c.361del" MANESelect="true">
            <Expression>NM_001082486.2:c.361del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001075955.2" sequenceAccession="NP_001075955" sequenceVersion="2" change="p.Asp121fs">
            <Expression>NP_001075955.2:p.Asp121fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022914.3" sequenceAccession="NM_022914" sequenceVersion="3" change="c.352del">
            <Expression>NM_022914.3:c.352del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_075065.3" sequenceAccession="NP_075065" sequenceVersion="3" change="p.Asp118fs">
            <Expression>NP_075065.3:p.Asp118fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1237t1" sequenceAccession="LRG_1237t1">
            <Expression>LRG_1237t1:c.361del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1237p1" sequenceAccession="LRG_1237p1" change="p.Asp121fs">
            <Expression>LRG_1237p1:p.Asp121fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1237" sequenceAccession="LRG_1237">
            <Expression>LRG_1237:g.6227del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1303559181" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
        <XRef ID="0347" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001082486.2(ACD):c.361del (p.Asp121fs) AND Dyskeratosis congenita, autosomal dominant 6" Accession="RCV001523791" Version="1">
        <ClassifiedConditionList TraitSetID="22740">
          <ClassifiedCondition DB="MedGen" ID="C4225284">Dyskeratosis congenita, autosomal dominant 6</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-06-19" MostRecentSubmission="2021-06-19">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="22740" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="34297" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dyskeratosis congenita, autosomal dominant 6</ElementValue>
                <XRef ID="MONDO:0014690" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DKCA6</ElementValue>
                <XRef Type="MIM" ID="616553" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16136" />
                <XRef ID="16136" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Dyskeratosis congenita and related telomere biology disorders (DC/TBD) are caused by impaired telomere maintenance resulting in short or very short telomeres. The phenotypic spectrum of telomere biology disorders is broad and includes individuals with classic dyskeratosis congenita (DC) as well as those with very short telomeres and an isolated physical finding. Classic DC is characterized by a triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia, although this may not be present in all individuals. People with DC/TBD are at increased risk for progressive bone marrow failure (BMF), myelodysplastic syndrome or acute myelogenous leukemia, solid tumors (usually squamous cell carcinoma of the head/neck or anogenital cancer), and pulmonary fibrosis. Other findings can include eye abnormalities (epiphora, blepharitis, sparse eyelashes, ectropion, entropion, trichiasis), taurodontism, liver disease, gastrointestinal telangiectasias, and avascular necrosis of the hips or shoulders. Although most persons with DC/TBD have normal psychomotor development and normal neurologic function, significant developmental delay is present in both forms; additional findings include cerebellar hypoplasia (Hoyeraal Hreidarsson syndrome) and bilateral exudative retinopathy and intracranial calcifications (Revesz syndrome and Coats plus syndrome). Onset and progression of manifestations of DC/TBD vary: at the mild end of the spectrum are those who have only minimal physical findings with normal bone marrow function, and at the severe end are those who have the diagnostic triad and early-onset BMF.</Attribute>
                <XRef ID="NBK22301" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301779</ID>
                <ID Source="BookShelf">NBK22301</ID>
              </Citation>
              <XRef ID="3322" DB="Orphanet" />
              <XRef ID="C4225284" DB="MedGen" />
              <XRef ID="MONDO:0014690" DB="MONDO" />
              <XRef Type="MIM" ID="616553" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2894064" SubmissionDate="2021-01-05" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="SUB7472183" submittedAssembly="GRCh38" title="SUB7472183" />
        <ClinVarAccession Accession="SCV001450737" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Bertuch Lab, Baylor College of Medicine" OrgID="507015" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant consists of deletion of a single nucleotide in exon 4, resulting in frameshift and production of a premature termination codon in exon 5. When heterozygous, this variant, which was studied in a father and son, produced no clinical phenotype. Telomere length by flow-FISH analysis in the two individuals revealed lymphocyte telomere lengths that were within normal range. When compound heterozygous with an in-frame deletion of amino acid E169, this variant resulted in extremely short telomeres and severe clinical phenotypes.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Ethnicity>Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Baylor Genetics</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001511" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000252" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001508" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000750" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0005372" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002242" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0005528" />
              </Trait>
            </TraitSet>
            <Comment>Variant was identified by exome sequencing and confirmed by Sanger sequencing. When compound heterozygous with an in-frame deletion of amino acid E169, this variant resulted in extremely short telomeres and severe clinical phenotypes, including intrauterine growth restriction, microcephaly, failure to thrive, speech delay, severe B cell deficiency with associated life-threatening infections, severe enteropathy, and hypocellular bone marrow. Telomere lengths were around 4.0 - 4.5 kb in all five measurable leukocyte populations (the B cell number was too low for analysis), well below the 1st centile for age. The clinical features, genetics, and telomere lengths led to a diagnosis of Hoyeraal-Hreidarsson syndrome.</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Ethnicity>Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>no</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Baylor Genetics</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <Comment>Variant was identified by exome sequencing and confirmed by Sanger sequencing. When heterozygous, no clinical phenotype was observed. Indication for testing: Parental study This individual had normal complete blood count and telomere lengths near the 50th percentile for age.</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>paternal</Origin>
              <Ethnicity>Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>no</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <TypePlatform>Next-generation exome sequencing</TypePlatform>
              <MethodType>clinical testing</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="TestingLaboratory">Baylor Genetics</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <Comment>Variant was identified by exome sequencing and confirmed by Sanger sequencing. When heterozygous, no clinical phenotype was observed. Indication for clinical testing: Sibling study This individual had normal complete blood count and telomere lengths near the 50th percentile for age.</Comment>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>in vitro</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Sanger sequencing of genomic and complementary DNA revealed markedly reduced levels of the variant transcript in cells. Alongside in silico analysis, this led us to conclude that this transcript is targeted for nonsense mediated decay.</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACD">
              <Name>ACD shelterin complex subunit and telomerase recruitment factor</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_001082486.1:exon 4</GeneLocation>
          </Location>
          <FunctionalConsequence Value="RNA degradation by nonsense-mediated decay">
            <XRef DB="Variation Ontology" ID="0347" URL="http://purl.obolibrary.org/obo/VariO_0347" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001082486.1:c.619delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616553" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7472183</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002242" MappingRef="HP">
        <MedGen CUI="C4316788" Name="Abnormal intestine morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000252" MappingRef="HP">
        <MedGen CUI="C4551563" Name="Microcephaly" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Disease" MappingType="XRef" MappingValue="616553" MappingRef="OMIM">
        <MedGen CUI="C4225284" Name="Dyskeratosis congenita, autosomal dominant 6" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001511" MappingRef="HP">
        <MedGen CUI="C0015934" Name="Fetal growth restriction" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005372" MappingRef="HP">
        <MedGen CUI="C1849242" Name="Abnormality of B cell physiology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000750" MappingRef="HP">
        <MedGen CUI="C0454644" Name="Delayed speech and language development" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0005528" MappingRef="HP">
        <MedGen CUI="C1855710" Name="Bone marrow hypocellularity" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2894064" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001508" MappingRef="HP">
        <MedGen CUI="C2315100" Name="Failure to thrive" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>